Concurrent and adjuvant docetaxel with three-dimensional conformal radiation therapy plus androgen deprivation for high-risk prostate cancer: Preliminary results of a multicentre phase II trial-Reference-Cited by-同舟云学术

Concurrent and adjuvant docetaxel with three-dimensional conformal radiation therapy plus androgen deprivation for high-risk prostate cancer: Preliminary results of a multicentre phase II trial

Published:2010-11 Issue:2 Volume:97 Page:312-317
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Bolla Michel,Hannoun-Levi Jean Michel,Ferrero Jean-Marc,Maingon Philippe,Buffet-Miny Joëlle,Bougnoux Agnès,Bauer Jacques,Descotes Jean-Luc,Fourneret Philippe,Jover Florence,Colonna Marc

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology

Reference30 articles.

1. Cancer statistics, 2006;Jemal;CA Cancer J Clin,2006

2. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer;Zelefsky;Int J Radiat Oncol Biol Phys,1998

3. Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85–31;Pilepich;J Clin Oncol,1997

4. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin;Bolla;N Engl J Med,1997

5. Systemic treatment and new developments in advanced prostate cancer;Sternberg;Eur J Cancer,2001

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Secondary analysis of late major gastrointestinal and genitourinary toxicities in unfavorable‐risk prostate cancer patients receiving docetaxel: Insights from a randomized trial;Cancer;2024-03

2. Long-Term Outcomes of a Phase I Trial of Weekly Docetaxel, Total Androgen Blockade, and Image Guided Intensity Modulated Radiation Therapy for Localized High-Risk Prostate Adenocarcinoma;Advances in Radiation Oncology;2022-11

3. Radiation and Androgen Deprivation Therapy With or Without Docetaxel in the Management of Nonmetastatic Unfavorable-Risk Prostate Cancer: A Prospective Randomized Trial;Journal of Clinical Oncology;2021-09-10

4. Harnessing the potential of multimodal radiotherapy in prostate cancer;Nature Reviews Urology;2020-05-01

5. Phase I Trial of Weekly Cabazitaxel with Concurrent Intensity Modulated Radiation and Androgen Deprivation Therapy for the Treatment of High-Risk Prostate Cancer;International Journal of Radiation Oncology*Biology*Physics;2020-04